Loading organizations...
Arctic Bioscience AS is a biotechnology company based in Ørsta, Norway, that develops and commercializes pharmaceutical and nutraceutical products extracted from herring roe. The organization focuses on creating premium marine dietary supplements and proprietary pharmaceutical drug candidates, including a novel oral treatment for mild to moderate psoriasis. Operating with 21 to 50 employees, the publicly traded enterprise generated NOK 33.8 million in total revenue during 2023 and holds an estimated valuation of $12.3 million. In January 2024, the firm successfully completed patient recruitment for the Phase IIb clinical trial of its lead pharmaceutical candidate, HRO350. Listed on the Euronext Growth Oslo exchange, the company was founded in 2011 by Harald Nordal and Hogne Hallaråker, and is managed by a leadership team that includes chief executive officer Christer Valderhaug and chief technology officer Daniele Mancinelli.
Arctic Bioscience AS has raised $280K across 1 funding round.
Arctic Bioscience AS has raised $280K in total across 1 funding round.
Arctic Bioscience is a Norwegian biotechnology company that develops pharmaceutical and nutraceutical ingredients from marine membrane lipids—primarily extracts from herring roe—targeting autoimmune/dermatological therapies and premium Omega‑3 products for consumer and B2B markets[2][3]. Arctic Bioscience sells nutraceuticals under the Romega™ brand while advancing an oral pharmaceutical candidate for mild‑to‑moderate psoriasis and other autoimmune indications, and operates R&D and production from Ørsta with an Oslo presence in the science park ecosystem[2][3].
High‑level overview
Origin story
Core differentiators
Role in the broader tech / biotech landscape
Quick take & future outlook
Arctic Bioscience AS has raised $280K across 1 funding round. Most recently, it raised $280K Series B in March 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2021 | $280K Series B | — | 10X Investor Club | Announced |
Arctic Bioscience AS has raised $280K in total across 1 funding round.
Arctic Bioscience AS's investors include 10x Investor Club.